Shopping Cart
- Remove All
- Your shopping cart is currently empty
Tanomastat is an orally bioavailable and non-peptidic biphenyl matrix metalloproteinases inhibitor. For MMP-2, MMP-3, MMP-9, MMP-13 the Ki values are 11, 143, 301, and 1470 nM respectively.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
500 μg | $88 | 35 days | |
1 mg | $170 | 35 days | |
5 mg | $540 | 35 days | |
10 mg | $990 | 35 days |
Description | Tanomastat is an orally bioavailable and non-peptidic biphenyl matrix metalloproteinases inhibitor. For MMP-2, MMP-3, MMP-9, MMP-13 the Ki values are 11, 143, 301, and 1470 nM respectively. |
Targets&IC50 | MMP2:11 nM (ki), MMP13:1470 nM (ki), MMP9:301 nM (ki), MMP3:143 nM (ki) |
In vitro | Tanomastat (1-00 μM; 5 days) inhibits tubule formation completely at 15-100 μM. Tanomastat (1-10000 nM; 6 hours) prevents matrix invasion by endothelial cells in a concentration-dependent manner (IC50=840 nM) [2][3]. |
In vivo | Tanomastat (100 mg/kg; p.o.; daily for a 7-week period) inhibits local tumor regrowth and inhibits the number and volume of lung metastases [3]. |
Alias | BAY 12-9566 |
Molecular Weight | 410.91 |
Formula | C23H19ClO3S |
Cas No. | 179545-77-8 |
Relative Density. | 1.33g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.